{"id":541896,"date":"2021-05-05T19:08:01","date_gmt":"2021-05-05T19:08:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=541896"},"modified":"2021-05-05T19:08:01","modified_gmt":"2021-05-05T19:08:01","slug":"dual-chamber-prefilled-syringes-market-expected-to-reach-usd-2233-million-by-2028-with-top-players-gerresheimer-ag-nipro-corporation-credence-medsystems-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dual-chamber-prefilled-syringes-market-expected-to-reach-usd-2233-million-by-2028-with-top-players-gerresheimer-ag-nipro-corporation-credence-medsystems-and-others_541896.html","title":{"rendered":"Dual Chamber Prefilled Syringes Market Expected To Reach USD 223.3 Million By 2028 With Top Players Gerresheimer AG, Nipro Corporation, Credence Medsystems And Others."},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1620131981.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Dual Chamber Prefilled Syringes Market Expected To Reach USD 223.3 Million By 2028 With Top Players Gerresheimer AG, Nipro Corporation, Credence Medsystems And Others.\" src=\"https:\/\/www.abnewswire.com\/uploads\/1620131981.jpeg\" alt=\"Dual Chamber Prefilled Syringes Market Expected To Reach USD 223.3 Million By 2028 With Top Players Gerresheimer AG, Nipro Corporation, Credence Medsystems And Others.\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Reports And Data<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Growing demand for advanced devices to provide controlled drugs is a significant factor influencing growth of the market.<br \/>\nDual Chamber Prefilled Syringes Market Size \u2013 USD 130 million in 2020, Market Growth \u2013 at a CAGR of 7%, Market Trends \u2013Increasing demand for advanced drugs supplying devices\n<\/div>\n<p style=\"text-align: justify;\">The&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market\">dual chamber prefilled syringes market&nbsp;<\/a>is expected to be valued at USD 223.3 million by end of 2028 from a value of USD 130 million in 2020, expanding at a CAGR of 7% over the forecast period. Double-chamber syringes are designed as a drug and device combination product, which enables the reconstitution and administration of drugs in fixed doses. This growth of the market is attributable to the factors such as growing inclination toward lyophilized drugs, bio-based medicines across the globe, robust applications across administration of drugs, and demand for improved drug administration. Rising drugs administration activities along with growing adoption of dual chamber prefilled syringes for better administration is driving growth of its market.<\/p>\n<p style=\"text-align: justify;\">Additionally, the rising government initiatives for penetration of dual chamber prefilled syringes in the form of regulatory norms to propel its adoption from end users such as hospitals and other home-based care facilities. These norms are fueling growth of the dual chamber prefilled syringes market. With use of such devices, the medical procedures save time of treatment and enhance comfort to end users including patients and caregivers are estimated to drive market growth over the forecast period.<\/p>\n<p style=\"text-align: justify;\"><strong>Get a sample of the report @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/sample-enquiry-form\/3907\">https:\/\/www.reportsanddata.com\/sample-enquiry-form\/3907<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Key Findings from the Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>One of the key players, Otsuka America Pharmaceutical Inc.is focusing on countries in the Asia Pacific to generate its business.\n<\/li>\n<li>The hemophilia segment hold the largest share in the overall dual chamber prefilled syringes market in 2020 and is projected to hold significant share over the forecast period. The segmental growth is attributable to the robust number of patients suffering from the diseases across the globe.\n<\/li>\n<li>The glass segment hold the largest share in the overall dual chamber prefilled syringes market in 2020 and is projected to hold significant share over the forecast period. This growth of the segment is attributable to the growing its demand owing to benefits offered by material such as non-reactivity to different drugs.\n<\/li>\n<li>The North America is projected to hold largest share in the global dual chamber prefilled syringes market and to retain over the forecast period. This growth is attributable to the aging population, coupled with medical device manufacturing capacity. Additionally, the factors such as increased health awareness among consumers, affordability of consumers, and increased per capita spending in the region is driving growth of the regional market.\n<\/li>\n<li><strong>Key players in the dual chamber prefilled syringes market are Gerresheimer AG, Nipro Corporation, Credence Medsystems, Vetter Pharma, Arte Corporation, and MAEDA INDUSTRY.\n<p><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Buy Now: <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/checkout-form\/3907\">https:\/\/www.reportsanddata.com\/checkout-form\/3907<\/a><\/p>\n<p style=\"text-align: justify;\">For the purpose of this report, Reports and Data has segmented the global dual chamber prefilled syringes market on the basis of type, product, platform, end user, and region:<\/p>\n<p style=\"text-align: justify;\"><strong>By Material<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Glass<\/li>\n<li>Plastic\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>By Application<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Liquid\/Powder<\/li>\n<li>Liquid\/Liquid\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>By Product<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>1 ml-2.5 ml<\/li>\n<li>2.5 ml-5.0 ml<\/li>\n<li>&gt;5.0 ml\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>By Indication<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Hemophilia<\/li>\n<li>Schizophrenia<\/li>\n<li>Diabetes<\/li>\n<li>Erectile Dysfunction<\/li>\n<li>Endometriosis<\/li>\n<li>Others\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>By Region&nbsp;Outlook (Revenue, USD Billion; 2018-2028)<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America<\/li>\n<ul>\n<li>U.S.<\/li>\n<li>Canada<\/li>\n<\/ul>\n<li>Europe<\/li>\n<ul>\n<li>Germany<\/li>\n<li>UK<\/li>\n<li>France<\/li>\n<li>BENELUX<\/li>\n<li>Rest of Europe<\/li>\n<\/ul>\n<li>Asia Pacific<\/li>\n<ul>\n<li>China<\/li>\n<li>Japan<\/li>\n<li>South Korea<\/li>\n<li>Rest of APAC<\/li>\n<\/ul>\n<li>MEA<\/li>\n<ul>\n<li>Saudi Arabia<\/li>\n<li>UAE<\/li>\n<li>Rest of MEA<\/li>\n<\/ul>\n<li>Latin America<\/li>\n<ul>\n<li>Brazil<\/li>\n<li>Rest of LATAM\n<\/li>\n<\/ul>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>To identify the key trends in the industry, click on the link below:&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market\">https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Table Of Content: <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chapter 1. &nbsp; &nbsp;Market Synopsis<\/strong><br \/> &nbsp; &nbsp; 1.1. &nbsp; &nbsp;Market Definition<br \/> &nbsp; &nbsp; 1.2. &nbsp; &nbsp;Research Scope &amp; Premise<br \/> &nbsp; &nbsp; 1.3. &nbsp; &nbsp;Methodology<br \/> &nbsp; &nbsp; 1.4. &nbsp; &nbsp;Market Estimation Technique<br \/> <strong>Chapter 2. &nbsp; &nbsp;Executive Summary<\/strong><br \/> &nbsp; &nbsp; 2.1. &nbsp; &nbsp;Summary Snapshot, 2019-2027<br \/> <strong>Chapter 3. &nbsp; &nbsp;Indicative Metrics<\/strong><br \/> <strong>Chapter 4. &nbsp; &nbsp;Dual Chamber Prefilled Syringes Market Segmentation &amp; Impact Analysis<\/strong><br \/> &nbsp; &nbsp; 4.1. &nbsp; &nbsp;Dual Chamber Prefilled Syringes Market Material Segmentation Analysis<br \/> &nbsp; &nbsp; 4.2. &nbsp; &nbsp;Industrial Outlook<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.1. &nbsp; &nbsp;Market indicators analysis<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4.2.2. &nbsp; &nbsp;Market drivers&rsquo; analysis<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.2.2.1. &nbsp; &nbsp;Growing biopharmaceutical industry&nbsp;<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.2.2.2. &nbsp; &nbsp;Growing demand for drug delivery devices for lyophilic drugs&nbsp;<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.2.2.3. &nbsp; &nbsp;Lesser risk of contamination&nbsp;<\/p>\n<p style=\"text-align: justify;\">&hellip;<\/p>\n<p style=\"text-align: justify;\"><strong>Chapter 10. &nbsp; &nbsp;Competitive Landscape<\/strong><br \/> &nbsp; &nbsp; 10.1. &nbsp; &nbsp;Market Revenue Share By Manufacturers<br \/> &nbsp; &nbsp; 10.2. &nbsp; &nbsp;Manufacturing Cost Breakdown Analysis<br \/> &nbsp; &nbsp; 10.3. &nbsp; &nbsp;Mergers &amp; Acquisitions<br \/> &nbsp; &nbsp; 10.4. &nbsp; &nbsp;Market positioning<br \/> &nbsp; &nbsp; 10.5. &nbsp; &nbsp;Strategy Benchmarking<br \/> &nbsp; &nbsp; 10.6. &nbsp; &nbsp;Vendor Landscape<br \/> <strong>Chapter 11. &nbsp; &nbsp; Company Profiles &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<\/strong><br \/> &nbsp; &nbsp; 11.1. &nbsp; &nbsp;Hewlett Packard Enterprise Company<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.1.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.1.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.1.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.1.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.2. &nbsp; &nbsp;Ultimaco GmbH<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.2.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.2.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.2.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.2.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.3. &nbsp; &nbsp;Atos SE<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.3.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.4. &nbsp; &nbsp;SWIFT<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.4.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.4.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.4.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.4.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.5. &nbsp; &nbsp;Yubico<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.5.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.6. &nbsp; &nbsp;Futurex<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.6.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.6.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.6.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;11.6.4. &nbsp; &nbsp;Strategic Initiatives<br \/> &nbsp; &nbsp; 11.7. &nbsp; &nbsp;Thales E-Security Inc.<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.1. &nbsp; &nbsp;Company Overview<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.2. &nbsp; &nbsp;Financial Performance<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.3. &nbsp; &nbsp;Technology Insights<br \/> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11.7.4. &nbsp; &nbsp;Strategic Initiatives<\/p>\n<p style=\"text-align: justify;\"><strong>Continue&hellip;.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About Us:<\/strong><\/p>\n<p style=\"text-align: justify;\">Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/reportsanddata.com_38777.html\" rel=\"nofollow\">Reports and Data<\/a><br \/><strong>Contact Person:<\/strong> John Watson<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=dual-chamber-prefilled-syringes-market-expected-to-reach-usd-2233-million-by-2028-with-top-players-gerresheimer-ag-nipro-corporation-credence-medsystems-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1-212-710-1370<br \/><strong>Address:<\/strong>40 Wall St. 28th floor  <br \/><strong>City:<\/strong> New York City<br \/><strong>State:<\/strong> NY 10005<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.reportsanddata.com\/report-detail\/dual-chamber-prefilled-syringes-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=dual-chamber-prefilled-syringes-market-expected-to-reach-usd-2233-million-by-2028-with-top-players-gerresheimer-ag-nipro-corporation-credence-medsystems-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reports And Data Growing demand for advanced devices to provide controlled drugs is a significant factor influencing growth of the market. Dual Chamber Prefilled Syringes Market Size \u2013 USD 130 million in 2020, Market Growth \u2013 at a CAGR of &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/dual-chamber-prefilled-syringes-market-expected-to-reach-usd-2233-million-by-2028-with-top-players-gerresheimer-ag-nipro-corporation-credence-medsystems-and-others_541896.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,412,406,404],"tags":[],"class_list":["post-541896","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-News-Current-Affairs","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/541896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=541896"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/541896\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=541896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=541896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=541896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}